Medullary Thyroid Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS safety_alert · 2016-08-31
Clinical Trial Update: Vandetanib Risk Minimisation Effectiveness
This update reports on the effectiveness of risk minimisation measures for vandetanib in medullary thyroid carcinoma, based on the completed…